Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Adding Artificial Intelligence (AI) System to Breast Ultrasound Can Reduce Unnecessary Biopsies, Finds Study

By HospiMedica International staff writers
Posted on 11 Mar 2021
A new study has determined that artificial intelligence (AI) can be an adjunct tool for breast ultrasound to reduce excessive lesion biopsy.

Researchers at Peking University Third Hospital (Beijing, China) conducted a study to determine whether adding an AI system to breast ultrasound can reduce unnecessary biopsies. More...
In the study, conventional ultrasound and AI analyses were prospectively performed on 173 suspicious breast lesions before ultrasound-guided core needle biopsy or vacuum-assisted excision. Conventional ultrasound images were retrospectively reviewed according to the BI-RADS 2013 lexicon and categories. Two downgrading stratifications based on AI assessments were manually used to downgrade the BI-RADS category 4A lesions to category 3. Stratification A was used to downgrade if the assessments of both orthogonal sections of a lesion from AI were possibly benign. Stratification B was used to downgrade if the assessment of any of the orthogonal sections was possibly benign. The effects of AI-based diagnosis on lesions to reduce unnecessary biopsy were analyzed using histopathological results as reference standards.

The researchers found that 43 lesions diagnosed as BI-RADS category 4A by conventional ultrasound received AI-based hypothetical downgrading. While downgrading with stratification A, 14 biopsies were correctly avoided. The biopsy rate for BI-RADS category 4A lesions decreased from 100% to 67.4% (P <  0.001). While downgrading with stratification B, 27 biopsies could be avoided with two malignancies missed, and the biopsy rate decreased to 37.2% (P <  0.05, compared with conventional ultrasound and stratification A). Based on their findings, the researchers concluded that adding an AI system to breast ultrasound could reduce unnecessary lesion biopsies and have recommended downgrading stratification A for its lower misdiagnosis rate.

Related Links:
Peking University Third Hospital


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Emergency Ventilator
Shangrila935
Semi‑Automatic Defibrillator
Heart Save AED (ED300)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.